Document:

LOAN
AGREEMENT (Amendment 4) made effective January 22, 2016 (the “Effective Date”) between Mercuriali Ltd.,
a limited company incorporated pursuant to the laws of England and Wales (hereinafter referred to as “Mercuriali”)
and Samuel Asculai of the City of Toronto (hereinafter “Asculai”) and Enhance Skin Products Inc.,
a corporation incorporated pursuant to the laws of the State of Nevada (hereinafter referred to as “Enhance”)

 

WHEREAS
Mercuriali, Asculai and Enhance are parties to a Loan Agreement dated March 4, 2013 (hereinafter the “Loan Agreement”),
a Loan Agreement (Amendment 1) made effective September 20, 2013 (hereinafter “Amendment Agreement 1), a Loan Agreement
(Amendment 2) made effective March 3, 2014 (hereinafter “Amendment Agreement 2) and a Loan Agreement (Amendment 3) made
effective September 29, 2015 (hereinafter “Amendment Agreement 3);

 

AND
WHEREAS Enhance and Vis Vires Group Inc. are parties to a Convertible Promissory Note dated June 19, 2015 (“The Vis Vires
Promissory Note”) and a Securities Purchase Agreement dated June 19, 2015 (“The Vis Vires Securities Purchase Agreement”);

 

AND
WHEREAS the parties wish to amend the Loan Agreement, Amendment Agreement 1,Amendment Agreement 2 and Amendment Agreement 3;

 

NOW
THEREFORE THIS AGREEMENT WITNESSETH that in consideration of the mutual covenants contained herein, and other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, it is hereby agreed as follows:

 

1.
Loan Amounts.

 

	(a)	As
    of October 31, 2015 (“Amended Reporting Date”), Asculai has loaned Enhance $96,489 under the Loan Agreement (hereinafter
    the “Asculai Loan Amount”). The Asculai Loan Amount will be increased by any amount loaned by Asculai to Enhance
    since the Amended Reporting Date or during the term of this Agreement. 
	 	 
	(b)	As
    of the Amended Reporting Date, Enhance owes Mercuriali $214,832 under the Loan Agreement (hereinafter “the “Mercuriali
    Loan Amount”) and $14,940 under the Additional Mercuriali Loan Amount. The Mercuriali Loan Amount will be increased
    in the event that Mercuriali loans additional monies to Enhance since the Amended Reporting Date or during the term of this
    Agreement.
	 	 
	(c)	Asculai
    and Mercuriali have agreed jointly or individually to increase the additional loan under Amendment 3 from $45,000 to $90,000
    (“The Additional Asculai Loan Amount” and/or “The Additional Mercuriali Loan Amount”) in the event
    no additional third party monies are received. 

 

    	 	 	 

    	 	 	 

    

 

2.
Amendment to Conversion Loan Amounts.

 

Section
3 of the Loan Agreement, as amended by Amendment Agreements 1, 2 and/or 3, is amended by deleting it and replacing it with the
following:

 

3.
Conversion of Loan Amounts.

 

(a)Upon
Enhance restructuring at least seventy five percent (75%) of its outstanding debt substantially in accordance with the restructuring
plan approved by the Board of Directors of Enhance on February 13, 2013, Asculai shall convert fifty percent (50%) of the Asculai
Loan Amount into common shares of Enhance at a conversion price of $0.00376 per share (the “Conversion Price”). Upon
Enhance receiving aggregate Transaction Monies (as defined below in Section 3(h)) of at least two hundred and fifty thousand United
States dollars (US$250,000) the remainder of the Asculai Loan Amount (the “Remaining Asculai Loan Amount”) shall become
unsecured and shall be repaid as set out in Section 4 below.

 

(b)Upon
Enhance restructuring at least seventy five percent (75%) of its outstanding debt substantially in accordance with the restructuring
plan approved by the Board of Directors of Enhance on February 13, 2013 and upon Enhance receiving aggregate Transaction Monies
(as defined below in Section 3(h)) of at least two hundred and fifty thousand United States dollars (US$250,000), Mercuriali shall
convert the Mercuriali Loan Amount into common shares of Enhance at the Conversion Price.

 

(c)Upon
Enhance receiving aggregate Transaction Monies (as defined below in Section 3(h) of at least two hundred and fifty thousand United
States dollars (US$250,000) (“Transaction Monies Threshold”), Mercuriali shall convert the Additional Mercuriali Loan
Amount into common shares of Enhance at the lower of $0.0047753 or the Average Vis Vires Conversion Price (as defined below in
Section 3(e)) (the “Additional Loan Conversion Price”).

 

(d)Upon
Enhance receiving aggregate Transaction Monies (as defined below in Section 3(g)) of at least two hundred and fifty thousand United
States dollars (US$250,000), Asculai shall convert the Additional Asculai Loan Amount into common shares of Enhance at the Additional
Loan Conversion Price.

 

(e)The
Vis Vires Conversion Price means the weighted average Conversion Price (as defined by The Vis Vires Promissory Note) at which
the Vis Vires Promissory Note, or portions thereof, convert prior to the date of conversion of the Additional Mercuriali Loan
Amount and the Additional Asculai Loan Amount under this Section 3. In the event that all or part of the Vis Vires Promissory
Note is repaid at a premium or discount to its face value, the Conversion Price applicable to that portion shall be such amount
taking into account the premium or discount paid, applied to the average price of the 3 lowest days in the 10 trading days preceding
the date of repayment on a similar basis to the Vis Vires Promissory Note, as if conversion had taken place. For greater certainty,
no conversion of any portion of the Vis Vires Promissory Note after the date of conversion of the Additional Mercuriali Loan Amount
and the Additional Asculai Loan Amount under this Section 3 shall be used in calculating the Vis Vires Conversion Price.

 

(f)In
the event of an Tender Offer for or an agreement for Enhance’s sale, merger, or other business combination (“Transaction”)
Mercuriali shall have the full right, but not the obligation, to convert the Mercuriali Loan Amount and The Additional Mercuriali
Loan Amount into common shares of Enhance at the Conversion Price or Additional Loan Conversion Price, as applicable, and to participate
in such Transaction on an equal basis to existing shareholders of Enhance.

 

(g)In
the event of an Tender Offer for or an agreement for Enhance’s sale, merger, or other business combination (“Transaction”)
Asculai shall have the full right, but not the obligation, to convert The Additional Asculai Loan Amount into common shares of
Enhance at the Additional Loan Conversion Price and to participate in such Transaction on an equal basis to existing shareholders
of Enhance.

 

    	 	 	 

    	 	 	 

    

 

(h)Transaction
Monies shall mean any monies, and the total amount of any other readily realizable cash equivalents or other assets received by
Enhance or any of its affiliates from third parties, in respect of any debt financing, equity financing, sale of assets or royalty
interest, licensing fees or any other similar funding method including in consequence of any merger or sale of all or part of
the Corporation’s business.

 

3.
Conflicts.

 

Except
as set out in this Amendment Agreement, the Loan Agreement, Amendment Agreement 1, Amendment Agreement 2 and Amendment Agreement
3 are unaffected and shall continue in full force and effect in accordance with their terms. If there is any conflict between
any provision of this Amendment Agreement and the Loan Agreement, and/or Amendment Agreements 1, 2 and/or 3, the terms of this
Amendment Agreement shall prevail.

 

4.
Governing Law.

 

This
Amendment Agreement and all of the rights and obligations arising herefrom shall be interpreted and applied in accordance with
the laws of the State of Nevada and the courts of the State of Nevada shall have exclusive jurisdiction to determine all disputes
relating to the Agreement and all of the rights and obligations created hereby.

 

IN
WITNESS WHEREOF the parties here have caused this Agreement to be executed and delivered effective as of the date first written
above.

 

	MERCURIALI
    LTD.	 	ENHANCE
    SKIN PRODUCTS INC.	 	SAMUEL
    ASCULAI
		 	 	 	 
	 	 	 	 	 
	Donald
    Nicholson	 	Drasko
    Puseljic	 	 
	Chief
    Executive	 	General
    CounselEX-10.1

 Exhibit 10.1 

FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT 

This First Amendment to Executive Employment Agreement is effective as of January 1, 2016, by and between Nuverra
Environmental Solutions, Inc. (f/k/a Heckmann Corporation) (the “Company”) and Mark D. Johnsrud (the “Executive”) and hereby amends the Executive Employment Agreement, dated November 30, 2012, by and between
the Company and the Executive (the “Agreement”). 
 WHEREAS, since the effective date of the Agreement, the
Executive has determined and the Company and the Executive have mutually agreed that Executive’s base annual salary should be reduced; 

NOW, THEREFORE, in consideration of the parties’ desire to maintain the employment relationship, and pursuant to
Section 12.1 of the Agreement, the parties hereto agree as follows: 

1.        Section 3 of the Agreement is hereby amended by replacing the terms and
language of Section 3 in their entirety with, “Effective January 1, 2016 and continuing through December 31, 2016, the Company shall pay Executive a base salary in cash at the rate of $1.00 per annum, receipt of which is hereby
acknowledged by the Executive. Notwithstanding the foregoing, (i) during the Term, Executive’s base salary shall be periodically reviewed by the Compensation Committee of the Board, and the Compensation Committee may, in its sole and
absolute discretion, increase Executive’s base salary at any time; (ii) upon at least thirty (30) days advance written notice from the Executive to the Compensation Committee requesting an increased base salary in a specified amount,
the Company shall prospectively increase Executive’s base salary to an amount requested by Executive not to exceed $700,000 per annum; and (iii) unless otherwise mutually agreed in writing by the Company and the Executive, beginning on
January 1, 2017, Executive’s annual base salary shall be $700,000 per annum.” 

2.        Section 6 of the Agreement is hereby amended by adding the following
sentence at the end thereof: “While Executive’s base salary is $1.00 per annum, the Company shall provide to Executive the employee-paid portion of Company-provided health plan coverage as a taxable benefit to Executive.” 

3.        Section 7.1(b)(i) of the Agreement is hereby amended by striking
“Executive’s highest annual rate of base salary over the most recent twelve (12) months” and replacing such stricken language with “$700,000.” 

3.        Section 8.2(a)(i) of the Agreement is hereby amended by striking
“two and nine-tenths (2.9) times Executive’s annual base salary as in effect at the time of termination or immediately prior to the occurrence of the Change of Control, whichever is greater” and replacing such stricken language
with “$2,030,000.” 
 4.        No other provisions of the Agreement are
amended, and all other provisions remain in full force and effect. 

  
 -1- 

 IN WITNESS WHEREOF, the Company has caused this First Amendment to Employment
Agreement to be executed on its behalf by its duly authorized officer, and the Executive has executed this First Amendment to Employment Agreement as of the date first written above, but on the actual dates below. 

Executive 

	
	
	 /s/ Mark D. Johnsrud

	Mark D. Johnsrud

 Date: January 25, 2016 
  

			
	Nuverra Environmental Solutions, Inc.
		
	By:	 	 /s/ Joseph M. Crabb

		 	Joseph M. Crabb,
		 	 Executive Vice President, Chief Legal Officer

and Corporate Secretary

 Date: January 25, 2016 

  
 -2-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00253-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00253-of-00352.parquet"}]]